BoltzMol-1 and BoltzProt-1 marked a step toward reliable hit discovery and binder design

GabriCorso · x · 2026-11-18

Reflecting on Boltz's founding thesis — AI could move far more molecular discovery from experiments to computation — the team notes that BoltzMol-1 and BoltzProt-1 (released in June) took an important step toward reliable small-molecule hit discovery and protein binder design for challenging targets.

Related event: AI drug design startup Boltz raises $110M Series A as usage surges 50x(7 posts)→

Original post →

More from Research

Research channel →